| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Terbinafine EP Impurity B HCl |
特比萘芬EP雜質(zhì)B鹽酸鹽 |
176168-78-8 |
詳細(xì)
|
| sodium glycerophosphate |
甘油磷酸鈉 |
17603-42-8 |
詳細(xì)
|
| Methyl dichloropropionate |
二氯丙酸甲酯 |
17640-02-7 |
詳細(xì)
|
| Anagrelide impurity 10 |
阿那格雷雜質(zhì)10 |
17700-09-3 |
詳細(xì)
|
| Apixaban Impurity 41 |
阿哌沙班雜質(zhì)41 |
1777782-32-7 |
詳細(xì)
|
| Canagliflozin monohydrate |
卡格列凈一水合物 |
1809403-05-1 |
詳細(xì)
|
| Atorvastatin Impurity 51 |
阿托伐他汀雜質(zhì)51 |
1817798-20-1 |
詳細(xì)
|
| Rosuvastatin Impurity 115 |
瑞舒伐他汀雜質(zhì)115 |
1821422-50-7 |
詳細(xì)
|
| Tofatinib Impurity 34（HCI) |
托法替尼雜質(zhì)34（HCI) |
1821769-41-8 |
詳細(xì)
|
| Levosalbutamol hydrochloride USP related compound A |
鹽酸左旋沙丁胺醇USP相關(guān)化合物A |
1823256-56-9 |
詳細(xì)
|
| Ethyl eicosapentetraenolate |
二十碳四烯酸乙酯 |
1808-26-0 |
詳細(xì)
|
| Diphenhydramine EP Impurity C HCl |
苯海拉明EP雜質(zhì)C鹽酸鹽 |
1808-12-4 |
詳細(xì)
|
| Edoxaban Impurity 89 |
依度沙班雜質(zhì)89 |
17899-48-8 |
詳細(xì)
|
| Metformin Impurity 10 |
二甲雙胍雜質(zhì)10 |
178671-73-3 |
詳細(xì)
|
| Isoniazid impurity 1 |
異煙肼雜質(zhì)1（三氮唑） |
38634-05-8 |
詳細(xì)
|
| Lapatinib Impurity 15 |
拉帕替尼雜質(zhì)15 |
179246-45-8 |
詳細(xì)
|
| Brimonidine EP impurity E hydrochloride |
溴莫尼定EP雜質(zhì)E鹽酸鹽 |
1797986-78-7 |
詳細(xì)
|
| Sofosbuvir Impurity 28 |
索非布韋雜質(zhì)28 |
1946820-91-2 |
詳細(xì)
|
| Levothyroxine EP Impurity H |
左旋甲狀腺素EP雜質(zhì)H |
2055-97-2 |
詳細(xì)
|
| Amentoflavone |
毛異黃酮 |
20575-57-9 |
詳細(xì)
|
| Tetrabutylammonium hydroxide |
四丁基氫氧化銨 |
2052-49-5 |
詳細(xì)
|
| Drotaverine Impurity 21 |
屈他維林雜質(zhì)21 |
2050-46-6 |
詳細(xì)
|
| Irotinib impurity 2 |
依魯替尼雜質(zhì)2 |
2052279-49-7 |
詳細(xì)
|
| Mitiglinide (calcium salt, hydrate) |
米格列奈(鈣鹽,水合物) |
207844-01-7 |
詳細(xì)
|
| Ergosterol Impurity 4 |
麥角甾醇雜質(zhì)4 |
2061-64-5 |
詳細(xì)
|
| Oseltamivir Impurity147 |
奧司他韋雜質(zhì)147 |
204255-02-7 |
詳細(xì)
|
| Tedizolid Impurity 1 |
特地唑胺雜質(zhì)1 |
2044712-34-5 |
詳細(xì)
|
| Topiroxostat Impurity 4 |
托匹司他雜質(zhì)4 |
2044702-36-3 |
詳細(xì)
|
| Topiroxostat Impurity 3 |
托匹司他雜質(zhì)3 |
2044704-74-5 |
詳細(xì)
|
| Mexobamol impurity 2 |
美索巴莫雜質(zhì)2 |
2049-21-0 |
詳細(xì)
|
| Amlodipine Impurity 85 |
氨氯地平雜質(zhì)85 |
194472-27-0 |
詳細(xì)
|
| Roxatidine Impurity 2 HCl |
羅沙替丁雜質(zhì)2鹽酸鹽 |
195621-06-8 |
詳細(xì)
|
| Lapatinib Impurity 23 |
拉帕替尼雜質(zhì)23 |
202197-27-1 |
詳細(xì)
|
| Oseltamivir Impurity145 |
奧司他韋雜質(zhì)145 |
204254-98-8 |
詳細(xì)
|
| 2 - (aminooxy) acetic acid hydrochloride |
2-(氨基氧基)乙酸鹽酸鹽 |
20295-82-3 |
詳細(xì)
|
| (E)-3-(3,4-Bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid |
(E)-3-(3,4-雙((叔丁基二甲基硅烷基)氧基)苯基)丙烯酸 |
203118-32-5 |
詳細(xì)
|
| L-valinol |
L-纈氨醇 |
2026-48-4 |
詳細(xì)
|
| Tenofovir Impurity 62 |
替諾福韋雜質(zhì)62 |
1962114-92-6 |
詳細(xì)
|
| Rivaroxaban Impurity 89 |
利伐沙班雜質(zhì)89 |
19532-96-8 |
詳細(xì)
|
| Tenofovir Impurity 59 |
替諾福韋雜質(zhì)59 |
1796545-19-1 |
詳細(xì)
|
| Etocoxib impurity 11 |
依托考昔雜質(zhì)11 |
202409-31-2 |
詳細(xì)
|
| Palbociclib Impurity 30 |
帕布昔利布雜質(zhì)30 |
1974279-21-4 |
詳細(xì)
|
| 1,2-diaminopropane dihydrochloride |
1,2-二氨基丙烷 二鹽酸鹽 |
19777-67-4 |
詳細(xì)
|
| Potassium clavulanate impurity 13 |
克拉維酸鉀雜質(zhì)13 |
2015-16-9 |
詳細(xì)
|
| Thiamine EP Impurity C |
硫胺素EP雜質(zhì)C |
20166-17-0 |
詳細(xì)
|
| Levothyroxine EP Impurity I |
左旋甲狀腺素EP雜質(zhì)I |
2016-06-0 |
詳細(xì)
|
| Anagrelide impurity 11 |
阿那格雷雜質(zhì)11 |
20098-48-0 |
詳細(xì)
|
| Orlistat Impurity 44 |
奧利司他雜質(zhì)44 |
19740-72-8 |
詳細(xì)
|
| Galantamine impurity 9 |
加蘭他敏雜質(zhì)9 |
199014-26-1 |
詳細(xì)
|
| Methylphenidate EP impurity A (racemate) |
哌甲酯EP雜質(zhì)A（消旋體） |
19395-41-6 |
詳細(xì)
|
| Methylphenidate impurity 2 |
哌甲酯雜質(zhì)2 |
19395-39-2 |
詳細(xì)
|
| Lasmiditan Impurity 15 |
拉米地坦雜質(zhì)15 |
1903-67-9 |
詳細(xì)
|
| Sacubitril impurity 17 |
沙庫(kù)巴曲雜質(zhì)17 |
1884269-07-1 |
詳細(xì)
|
| Escitalopram Impurity 34 |
艾司西酞普蘭雜質(zhì)34 |
1881237-26-8 |
詳細(xì)
|
| 1,1,1-tribromoacetone |
1,1,1-三溴丙酮 |
3770-98-7 |
詳細(xì)
|
| Sofosbuvir Impurity 29 |
索非布韋雜質(zhì)29 |
1911578-88-5 |
詳細(xì)
|
| Mirtazapine EP Impurity C |
米氮平EP雜質(zhì)C |
191546-96-0 |
詳細(xì)
|
| Anagrelide impurity 20 |
阿那格雷雜質(zhì)20 |
183620-20-4 |
詳細(xì)
|
| Hydroxyasiatic acid |
羥基積雪草酸 |
18449-41-7 |
詳細(xì)
|
| Metronidazole Impurity 26 |
甲硝唑雜質(zhì)26 |
19182-82-2 |
詳細(xì)
|
| Lummakato impurities4 |
魯瑪卡托雜質(zhì)4 |
|
詳細(xì)
|
| p-methyl cinnamic acid |
對(duì)甲基肉桂酸 |
1866-39-3 |
詳細(xì)
|
| Terbinafine EP Impurity C |
特比萘芬EP雜質(zhì)C |
187540-01-8 |
詳細(xì)
|
| Oxytetracycline EP impurity D |
土霉素EP雜質(zhì)D |
18695-01-7 |
詳細(xì)
|
| Cyclosporin Impurity 5 |
環(huán)孢菌素雜質(zhì)5 |
1907654-63-0 |
詳細(xì)
|
| Warfarin EP Impurity C |
華法林EP雜質(zhì)C |
1896-62-4 |
詳細(xì)
|
| Pemetrexed Impurity 2 |
培美曲塞雜質(zhì)2 |
193281-00-4 |
詳細(xì)
|
| Propionate methanesulflate |
甲磺酸丙酯 |
1912-31-8 |
詳細(xì)
|
| 2,4,4 '- trichlorobiphenyl |
2,4,4′-三氯聯(lián)苯 |
7012-37-5 |
詳細(xì)
|
| Pyridoxine Impurity 8 |
吡哆醇雜質(zhì)8 |
19203-53-3 |
詳細(xì)
|
| Ethyl 1h-indazole-5-carboxylate |
1H-吲唑-5-甲酸乙酯 |
192944-51-7 |
詳細(xì)
|
| Tedizolid Impurity 2 |
特地唑胺雜質(zhì)2 |
2095840-91-6 |
詳細(xì)
|
| Finerenone impurity 3 |
非奈利酮雜質(zhì)3 |
2084136-51-4 |
詳細(xì)
|
| Oryzanol impurity 10 |
谷維素雜質(zhì)10 |
20972-08-1 |
詳細(xì)
|
| Topiramate EP Impurity A(Diacetonefructose) |
托吡酯EP雜質(zhì)A(果糖二丙酮、托吡酯相關(guān)化合物A) |
20880-92-6 |
詳細(xì)
|
| Doxorubicin EP Impurity A |
多柔比星EP雜質(zhì)A |
20830-81-3 |
詳細(xì)
|
| Ilutinib impurity 3 |
依魯替尼雜質(zhì)3 |
1839099-22-7 |
詳細(xì)
|
| Pyridoxine Impurity 6 |
吡哆醇雜質(zhì)6 |
19203-56-6 |
詳細(xì)
|
| Argatroban Impurity 55 |
阿加曲班雜質(zhì)55 |
1780572-69-1 |
詳細(xì)
|
| Lasmiditan Impurity SE |
拉米地坦雜質(zhì)SE |
|
詳細(xì)
|
| Tolvaptan impurity 4 |
托伐普坦雜質(zhì)4 |
176970-21-1 |
詳細(xì)
|
| Pimavanserin Impurity 12 |
匹莫范色林雜質(zhì)12 |
84697-13-2 |
詳細(xì)
|
| Eltrombopag Impurity 66 |
艾曲波帕雜質(zhì)66 |
18048-64-1 |
詳細(xì)
|
| Brexpiprazole Impurity 59 |
依匹哌唑雜質(zhì)59 |
1849603-58-2 |
詳細(xì)
|
| Pyridoxine Impurity 12 |
吡哆醇雜質(zhì)12 |
1805775-66-9 |
詳細(xì)
|
| Vitamin K2 Impurity 3 |
維生素K2雜質(zhì)3 |
20962-84-9 |
詳細(xì)
|
| Famotidine EP Impurity J HCl |
法莫替丁EP雜質(zhì)J鹽酸鹽 |
1798006-30-0 |
詳細(xì)
|
| Warfarin Impurity 18 |
華法林雜質(zhì)18 |
17834-03-6 |
詳細(xì)
|
| Amoxicillin Impurity 40 |
阿莫西林雜質(zhì)40(指定BP品牌：748） |
|
詳細(xì)
|
| Ceftizoxime Impurity 56 |
頭孢唑肟雜質(zhì)56 |
1824820-93-0 |
詳細(xì)
|
| Norepinephrine EP impurity f hydrochloride salt |
去甲腎上腺素EP雜質(zhì)F鹽酸鹽 |
20455-68-9 |
詳細(xì)
|
| (E)-Ethyl N-hydroxyacetimidate |
(E)-N-羥基乙酰亞胺酸乙酯 |
20703-41-7 |
詳細(xì)
|
| Oxytetracycline EP impurity E |
土霉素EP雜質(zhì)E |
18751-99-0 |
詳細(xì)
|
| Bendamustine Impurity 33 |
苯達(dá)莫司汀雜質(zhì)33 |
1869075-89-7 |
詳細(xì)
|
| Amikacin Impurity 17 |
阿米卡星雜質(zhì)17 |
1793053-90-3 |
詳細(xì)
|
| Mometasone Furoate Impurity 3 |
糠酸莫米松雜質(zhì)3 |
201601-32-3 |
詳細(xì)
|
| Indobufen Impurity 6 |
吲哚布芬雜質(zhì)6 |
1781917-78-9 |
詳細(xì)
|
| Lysine impurity 33 |
賴氨酸雜質(zhì)33 |
19460-99-3 |
詳細(xì)
|
| Rivaroxaban Impurity 88 |
利伐沙班雜質(zhì)88 |
1794804-53-7 |
詳細(xì)
|
| Indobufen Impurity 5 |
吲哚布芬雜質(zhì)5 |
1823992-40-0 |
詳細(xì)
|